Loading...
The Financial Express

Bangladesh witnesses rise in dengue cases

The Directorate General of Health Services (DGHS) reported 21 more...

UK scientific adviser says AstraZeneca vaccine works

The British government's Chief Scientific Adviser Patrick Vallance said on...

AstraZeneca facing questions over Covid-19 vaccine success rate

Days after grabbing headlines with its Covid-19 “vaccine for the...

Plasma treatment shows little benefit in severe COVID-19 cases

The following is a roundup of some of the latest...

Mutations not making COVID-19 virus able to spread more rapidly: Study

The COVID-19-causing coronavirus is mutating as it spreads around the...

Plasma therapy shows little benefit in Covid patients: Study

Using blood plasma from Covid-19 survivors to treat patients with...

WHO says world’s poorest must not be ‘trampled’ in Covid vaccine race

The world's poorest and most vulnerable must not be "trampled...

BioNTech hopeful of getting vaccine approval in mid-December

US and European regulators could approve Pfizer and BioNTech's experimental COVID-19 vaccine as early as mid-December, the German firm's chief executive said on Wednesday, following the release of positive trial results. BioNTech's Chief Executive Ugur Sahin said if all goes well, the US Food and Drug Administration could grant emergency-use...